These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 6095996)

  • 1. Metabolic studies of delta-9-tetrahydrocannabinol in cancer patients.
    Frytak S; Moertel CG; Rubin J
    Cancer Treat Rep; 1984 Dec; 68(12):1427-31. PubMed ID: 6095996
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolic disposition of delta 8-tetrahydrocannabinol and its active metabolites, 11-hydroxy-delta 8-tetrahydrocannabinol and 11-oxo-delta 8-tetrahydrocannabinol, in mice.
    Watanabe K; Yamamoto I; Oguri K; Yoshimura H
    Drug Metab Dispos; 1981; 9(3):261-4. PubMed ID: 6113937
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative pharmacology of Delta9-tetrahydrocannabinol and its metabolite, 11-OH-Delta9-tetrahydrocannabinol.
    Lemberger L; Martz R; Rodda B; Forney R; Rowe H
    J Clin Invest; 1973 Oct; 52(10):2411-7. PubMed ID: 4729039
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of orally and rectally administered delta 9-tetrahydrocannabinol on spasticity: a pilot study with 2 patients.
    Brenneisen R; Egli A; Elsohly MA; Henn V; Spiess Y
    Int J Clin Pharmacol Ther; 1996 Oct; 34(10):446-52. PubMed ID: 8897084
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Delta-9-tetrahydrocannabinol as an antiemetic.
    Anderson PO; McGuire GG
    Am J Hosp Pharm; 1981 May; 38(5):639-46. PubMed ID: 6269423
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of Tourette's syndrome with Delta 9-tetrahydrocannabinol (THC): a randomized crossover trial.
    Müller-Vahl KR; Schneider U; Koblenz A; Jöbges M; Kolbe H; Daldrup T; Emrich HM
    Pharmacopsychiatry; 2002 Mar; 35(2):57-61. PubMed ID: 11951146
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vivo metabolism of the methyl homologues of delta-8-tetrahydrocannabinol, delta-9-tetrahydrocannabinol and abn-delta-8-tetrahydrocannabinol in the mouse.
    Brown NK; Harvey DJ
    Biomed Environ Mass Spectrom; 1988 Apr; 15(7):389-98. PubMed ID: 2839260
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Studies on the beta-oxidative metabolism of delta 1- and delta 6-tetrahydrocannabinol in the mouse. The in vivo biotransformation of metabolites oxidized in the side chain.
    Harvey DJ; Leuschner JT
    Drug Metab Dispos; 1985; 13(2):215-9. PubMed ID: 2859171
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Urinary excretion profiles of 11-nor-9-carboxy-delta9-tetrahydrocannabinol and 11-hydroxy-delta9-THC: cannabinoid metabolites to creatinine ratio study IV.
    Fraser AD; Worth D
    Forensic Sci Int; 2004 Jul; 143(2-3):147-52. PubMed ID: 15240035
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of orally administered cannabis extract and delta-9-tetrahydrocannabinol in treating patients with cancer-related anorexia-cachexia syndrome: a multicenter, phase III, randomized, double-blind, placebo-controlled clinical trial from the Cannabis-In-Cachexia-Study-Group.
    ; Strasser F; Luftner D; Possinger K; Ernst G; Ruhstaller T; Meissner W; Ko YD; Schnelle M; Reif M; Cerny T
    J Clin Oncol; 2006 Jul; 24(21):3394-400. PubMed ID: 16849753
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetic factors in sex differences in Delta 9-tetrahydrocannabinol-induced behavioral effects in rats.
    Tseng AH; Harding JW; Craft RM
    Behav Brain Res; 2004 Sep; 154(1):77-83. PubMed ID: 15302113
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Simultaneous analysis of THC and its metabolites in blood using liquid chromatography-tandem mass spectrometry.
    Del Mar Ramirez Fernandez M; De Boeck G; Wood M; Lopez-Rivadulla M; Samyn N
    J Chromatogr B Analyt Technol Biomed Life Sci; 2008 Nov; 875(2):465-70. PubMed ID: 18922747
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of cannabidiol pretreatment on the kinetics of tetrahydrocannabinol metabolites in mouse brain.
    Bornheim LM; Kim KY; Li J; Perotti BY; Benet LZ
    Drug Metab Dispos; 1995 Aug; 23(8):825-31. PubMed ID: 7493549
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Single-dose pharmacokinetics and tolerability of oral delta-9- tetrahydrocannabinol in patients with amyotrophic lateral sclerosis.
    Joerger M; Wilkins J; Fagagnini S; Baldinger R; Brenneisen R; Schneider U; Goldman B; Weber M
    Drug Metab Lett; 2012 Jun; 6(2):102-8. PubMed ID: 22594565
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics of delta 9-tetrahydrocannabinol in rabbits following single or multiple intravenous doses.
    Leuschner JT; Harvey DJ; Bullingham RE; Paton WD
    Drug Metab Dispos; 1986; 14(2):230-8. PubMed ID: 2870899
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vivo metabolism of the n-butyl-homologues of delta 9-tetrahydrocannabinol and delta 8-tetrahydrocannabinol by the mouse.
    Brown NK; Harvey DJ
    Xenobiotica; 1988 Apr; 18(4):417-27. PubMed ID: 2840781
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hydrolysis of 11-palmitoyloxy-delta 9-tetrahydrocannabinol to 11-hydroxy-delta 9-tetrahydrocannabinol by cholesterol esterase and a lipase.
    Leighty EG
    Res Commun Chem Pathol Pharmacol; 1979 May; 24(2):393-6. PubMed ID: 461993
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantitative analysis for delta 9-THC, 11-hydroxy-delta 9-THC, and 9-carboxy-delta 9-THC in plasma using GC/CI-MS.
    Foltz RL; Hidy BJ
    NIDA Res Monogr; 1982; 42():99-118. PubMed ID: 6294528
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NTP Toxicology and Carcinogenesis Studies of 1-Trans-Delta(9)-Tetrahydrocannabinol (CAS No. 1972-08-3) in F344 Rats and B6C3F1 Mice (Gavage Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1996 Nov; 446():1-317. PubMed ID: 12594529
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Simultaneous determination of Delta9-tetrahydrocannabinol, 11-hydroxy-Delta9-tetrahydrocannabinol and 11-nor-9-carboxy- Delta9-tetrahydrocannabinol in human plasma by high-performance liquid chromatography/tandem mass spectrometry.
    Maralikova B; Weinmann W
    J Mass Spectrom; 2004 May; 39(5):526-31. PubMed ID: 15170748
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.